Peripheral Neuropathy in its simplest definition is damage to the peripheral nerves — nerves located outside the brain and spinal cord. It is a relatively common condition that is not isolated to any ...
UK-based Yasa has revealed a potentially game-changing in-wheel electric motor. Based on its record-breaking tiny axial flux motor, the new drive unit prototype can provide over 1,000 hp per wheel.
SAN FRANCISCO -- The investigational complement-targeting agent claseprubart was safe and led to significant improvements in generalized myasthenia gravis (MG), the phase II MaGic trial showed. The ...
A new, inexpensive urine test that measures two sugar alcohols, sorbitol and xylitol, is making it easier, faster, and far less expensive to identify a common inherited nerve disorder called ...
Dianthus Therapeutics Inc. (NASDAQ:DNTH) released topline data from the Phase 2 MaGic trial evaluating the safety and efficacy of claseprubart (DNTH103) in adults with acetylcholine receptor ...
For people suffering from the burning, tingling and shooting pain of neuropathy, current treatments are limited and often fail to bring lasting relief. But help may be on the horizon. Northeastern ...
Yasa’s axial flux motor set an unofficial record for the highest power-to-weight ratio. During testing, the slim drive unit delivered over 700 horsepower while tipping the scales at just 28.8 pounds ...
A new chapter in electric motor design may be underway, and it’s being written in the UK. Yasa Motors, based in Britain and owned by Mercedes, has developed a new electric motor that sets a new ...
Axial flux electric motor developer YASA announced it has achieved what it believes to be the highest power density for an electric motor ever, hailing the feat as an unofficial world record. If you ...
Lupus & You is a free educational series where people with lupus and their family and friends can learn more about the latest in lupus research and managing the disease. Our recent webinar, Lupus & ...
WAYNE, Pennsylvania (WPVI) -- One step at a time, those who are diagnosed with rare neuropathic conditions such as GBS or CIDP prove it's possible to get back on their feet. A great place to see their ...
Please provide your email address to receive an email when new articles are posted on . In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results